This page shows the latest lurasidone news and features for those working in and with pharma, biotech and healthcare.
Takeda and development partner Dainippon Sumitomo Pharma have won European approval for their schizophrenia treatment Latuda (lurasidone).
2013. Takeda's antipsychotic and Linepharma's Hemoprostol. Elsewhere in the CHMP opinions, Takeda received a recommendation for the use of Latuda (lurasidone) in the treatment of adults with schizophrenia.
Lurasidone, an antagonist of dopamine D2, serotonin 2A, serotonin 7, serotonin 2C and a partial agonist of serotonin 1A, is being marketed by Sunovion Pharmaceuticals.
US. Lurasidone. Latuda (Sunovion Pharmaceuticals). Schizophrenia. US an Puerto Rico. Paracetamol.
The move comes as DSP prepares to launch its schizophrenia drug lurasidone, which last month significantly outperformed placebo in late-stage trials. ... The acquisition gives DSP the sales and marketing infrastructure in the US it needs to commercialise
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
There's prostate cancer drug orteronel (TAK-700) and vedolizumab for Crohn's disease and ulcerative colitis, and then the atypical antipsychotic lurasidone. ... From among its product pipeline Smith picks prostate cancer drug orteronel (TAK-700),
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...